Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study

被引：0

作者：

Fiorillo, Loretta ^{[1
]}

Becker, Emily ^{[2
]}

de Lucas, Raul ^{[3
]}

Belloni-Fortina, Anna ^{[4
]}

Maes, Peter ^{[5
]}

Oberoi, Rajneet K. ^{[5
]}

Paris, Maria ^{[5
]}

Zhang, Wendy ^{[5
]}

Zhang, Zuoshun ^{[5
]}

Arkin, Lisa

机构：

[1] Univ Alberta, Stollery Childrens Hosp, Edmonton, AB, Canada

[2] Driscoll Childrens Hosp, Corpus Christi, TX USA

[3] Hosp Univ La Paz PPDS, Madrid, Spain

[4] Azienda Osped Univ Padova, Padua, Italy

[5] Amgen Inc, Thousand Oaks, CA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

42163

引用

页码：AB122 / AB122

页数：1

共 50 条

[11] Efficacy and safety of adalimumab versus methotrexate treatment in pediatric patients with severe chronic plaque psoriasis: Results from the 16-Week randomized, double-blind period of a phase 3 study
Papp, Kim
Thaci, Diamant
Marcoux, Danielle
Weibel, Lisa
Unnebrink, Kristina
Williams, David A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S15 - S15
[12] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
Bissonnette, R.
Haydey, R.
Rosoph, L. A.
Lynde, C. W.
Bukhalo, M.
Fowler, J. F.
Delorme, I.
Gagne-Henley, A.
Gooderham, M.
Poulin, Y.
Barber, K.
Jenkin, P.
Landells, I.
Pariser, D. M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410
[13] Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
Yan, Kexiang
Li, Fuqiu
Bi, Xiaodong
Han, Ling
Zhang, Zhenghua
Chen, Rixin
Li, Yuye
Zhang, Litao
Wang, Xiaohua
Li, Linfeng
Lu, Jianyun
Xu, Ai'e
Yang, Sen
Lu, Yan
Sun, Jianfang
Li, Zhiming
Zhu, Xiaohong
Jiang, Meiying
Zhang, Siping
Wang, Wenqing
Li, Yanling
Meng, Zudong
Li, Hongyi
Mou, Kuanhou
Han, Xiuping
Li, Shanshan
Chen, Aijun
Li, Xin
Liu, Donghua
Zhang, Chunlei
Ji, Chao
Wang, Yu
Cheng, Hao
Cui, Xiaojing
Yao, Xiaoyan
Bai, Xiaoyan
Dong, Guangchao
Xu, Jinhua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 92 - 99
[14] A phase IV randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of efatizumab in patients with moderate to severe plaque psoriasis involving the scalp
Kircik, Leon
Caro, Ivor
Schlessinger, Joel
Chen, Yun
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
[15] A randomized, double-blind placebo-controlled study of ustekinumab in Japanese patients with moderate to severe plaque psoriasis
Igarashi, A.
Kato, T.
Kato, M.
Nakagawa, H.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 17 - 17
[16] The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)
Reich, K.
Gooderham, M.
Green, L.
Bewley, A.
Zhang, Z.
Khanskaya, I.
Day, R. M.
Goncalves, J.
Shah, K.
Piguet, V.
Soung, J.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (03) : 507 - 517
[17] Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study
Papp, K. A.
Kaufmann, R.
Thaci, D.
Hu, C.
Sutherland, D.
Rohane, P.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (03) : e376 - e383
[18] Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial
Sofen, Howard L.
Gebauer, Kurt
Spelman, Lynda
Yamauchi, Paul S.
Yao, Siu-Long
Nishandar, Tushar
Kopeloff, Iris
Crane, Michael
Gogineni, Ranga
Kothekar, Mudgal
Bagel, Jerry
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (04) : 816 - 824
[19] Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double-blind, placebo-controlled study
Seo, Seong Jun
Shin, Bong Seok
Lee, Joo-Heung
Jeong, Haeyoun
JOURNAL OF DERMATOLOGY, 2021, 48 (06): : 807 - 817
[20] Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
Torrelo, A.
Rewerska, B.
Paller, Amy
Prakash, A.
Zhu, D.
Pontes, M.
Wu, Wen-Shuo
Eichenfield, Lawrence F.
Boecker, Ulrike
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 99

← 1 2 3 4 5 →